Atrovent HFA Side Effects
Generic name: ipratropium
Note: This document contains side effect information about ipratropium. Some of the dosage forms listed on this page may not apply to the brand name Atrovent HFA.
Some side effects of Atrovent HFA may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to ipratropium: inhalation aerosol, inhalation solution
Get emergency medical help if you have any of these signs of an allergic reaction while taking ipratropium (the active ingredient contained in Atrovent HFA) hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using ipratropium and call your doctor at once if you have a side effect such as:
bronchospasm (wheezing, chest tightness, trouble breathing), especially after starting a new canister of this medicine;
blurred vision, eye pain, or seeing halos around lights;
pain or burning when you urinate;
urinating less than usual or not at all; or
worsening of your symptoms.
Other common side effects may include:
stuffy nose, sinus pain, dry mouth, cough, hoarseness;
nausea, upset stomach, constipation;
back pain; or
fever, chills, body aches, flu symptoms.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to ipratropium: compounding powder, inhalation aerosol, inhalation solution
Most common adverse reactions were bronchitis, COPD exacerbation, dyspnea, headache
Common (1% to 10%): Headache, dizziness
Postmarketing reports: Skin rash, pruritus, angioedema (including that of tongue, lips and face), urticarial (including giant urticaria), laryngospasm and anaphylactic reactions
Frequency not reported: Precipitation or worsening of narrow-angle glaucoma, glaucoma, halo vision, conjunctival hyperemia, corneal edema, acute eye pain, blurred vision
Postmarketing reports: Mydriasis, increased intraocular pressure
Common (1% to 10%): Urinary tract infection
Postmarketing reports: Urinary retention
Very common (10% or more): Bronchitis, COPD exacerbation, sinusitis
Common (1% to 10%): Dyspnea, sinusitis, cough, rhinitis, upper respiratory infection
Postmarketing reports: Cough, bronchospasm (including paradoxical bronchospasm)
Frequency not reported: Hypotension, palpitations, tachycardia
Postmarketing reports: Supraventricular tachycardia, atrial fibrillation, increased heart rate
Common (1% to 10%): Dyspepsia, dry mouth, nausea
Uncommon (0.1% to 1%): Taste perversion (bitter taste)
Frequency not reported: Dry throat, constipation, throat irritation, stomatitis, mouth edema
Postmarketing reports: Gastrointestinal distress (diarrhea, nausea, vomiting), pharyngeal edema, gastrointestinal motility disorders
Common (1% to 10%): Back pain
Common (1% to 10%): Influenza-like symptoms
Postmarketing reports: Accommodation disorder
More Atrovent HFA resources
- Atrovent HFA Prescribing Information (FDA)
- Atrovent HFA aerosol suspension MedFacts Consumer Leaflet (Wolters Kluwer)
- Ipratropium Prescribing Information (FDA)
- Atrovent Monograph (AHFS DI)
- Atrovent Inhalation, oral/nebulization Advanced Consumer (Micromedex) - Includes Dosage Information
- Atrovent aerosol suspension MedFacts Consumer Leaflet (Wolters Kluwer)
- Atrovent Consumer Overview
- Atrovent Nasal Spray eent Monograph (AHFS DI)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.